(Q61811079)

English

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

scientific article published on 11 April 2011

Statements

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit